Table 3.
Intergroup comparison of clinical parameters and levels of sclerostin between the test and control groups at baseline
| Baseline | Mean±SD | T | P |
|---|---|---|---|
| GI | |||
| Control | 1.2833±0.50768 | −0.6990 | 0.496 (NS) |
| Test | 1.4333±0.67126 | ||
| BI | |||
| Control | 3.4000±0.63246 | 0.323 | 0.749 (NS) |
| Test | 3.3333±0.48795 | ||
| PPD (in mm) | |||
| Control | 5.13±0.352 | −0.475 | 0.345 (NS) |
| Test | 5.20±0.414 | ||
| CAL (in mm) | |||
| Control | 5.33±0.488 | −0.367 | 0.478 (NS) |
| Test | 5.40±0.507 | ||
| SOST (in pg/ml) | |||
| Control | 146.4667±49.78506 | 1.399 | 0.015 (S) |
| Test | 125.80±28.21145 |
P<0.05. S: Significant; NS: Nonsignificant; SD: Standard deviation; CAL: Clinical attachment level; GI: Gingival index; BI: Bleeding index; PPD: Probing pocket depth; SOST: Sclerostin